Discrimination of liver cirrhosis from chronic hepatitis by measuring the ratio of Aleuria aurantia lectin-reactive serum cholinesterase to immunoreactive protein

Clinica Chimica Acta

Volumn 281, Issue 1-2, 1999, Pages 37-46

  Hada, Toshikazu ^a   Kondo, Masahide ^b   Yasukawa, Kiyoshi ^b   Amuro, Yoshiki ^a   Higashino, Kazuya ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b TOSOH CORPORATION   (Japan)

Author keywords

Chronic liver disease; ELISA; Lectin; Sugar chain

Indexed keywords

BIOCHEMICAL MARKER; CHOLINESTERASE; HEPATITIS B SURFACE ANTIGEN; HYALURONIC ACID; LIVER PROTEIN; PLANT LECTIN;

ARTICLE; CHOLINESTERASE BLOOD LEVEL; CHRONIC HEPATITIS; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOREACTIVITY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

CHOLINESTERASES; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; LECTINS; LIVER CIRRHOSIS; SENSITIVITY AND SPECIFICITY;

ALEURIA AURANTIA;

EID: 0032996682     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00202-2     Document Type: Article

References (14)

1. Takayasu K., Muramatsu Y., Moriyama N.et al. Clinicopathological evaluation in the residual liver following hepatectomy in 97 patients with hepatocellular carcinoma. Jpn J Gastroent. 84:1987;1424-1432.
2. Okuda D., Fujimoto I., Hanai A., Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res. 47:1987;4967-4972.
3. Kobayashi K, Unoura M, Urabe T, et al. Screening of high risk group. In: Okuda K, Tobe T, Kitagawa T, editors. Early Detection and Treatment of Liver Cancer. Gann Monogr on Cancer Res No 38. Tokyo: Jpn Scientific Societies Press, 1991:53-57.
4. Kondo M., Hada T., Fukui K., Iwasaki A., Higashino K., Yasukawa K. Enzyme-linked immunosorbent assay (ELISA) for Aleuria aurantia lectin-reactive serum cholinesterase to differentiate liver cirrhosis and chronic hepatitis. Clin Chim Acta. 243:1995;1-9.
5. Ohkura T., Hada T., Higashino K.et al. Increase of fucosylated serum cholinesterase in relation to high risk groups for hepatocellular carcinomas. Cancer Res. 54:1994;55-61.
6. De Groote J., Desmet V.J., Gedigk P.et al. A classification of chronic hepatitis. Lancet. ii:1968;626-628.
7. Pugh R.N.H., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 60:1973;646-649.
8. Murawaki Y., Ikuta Y., Koda M., Nishimura Y., Kawasaki H. Clinical significance of serum hyaluronan in patients with chronic viral liver disease. J Gastroenterol Hepatol. 11:1996;459-465.
9. Guechot J., Laudat A., Loria A., Serafaty L., Poupon R., Giboudeau J. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem. 42:1996;558-563.
10. Hada T., Fukui K., Ohno M.et al. Increased plasma α(1→3)-L-fucosyltransferase activities in patients with hepatocellular carcinoma. Glycoconjugate J. 12:1995;627-631.
11. Hutchinson W.L., Du M.Q., Johnson P.J.et al. Fucosyltransferases: differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis. Hepatology. 13:1991;683-688.
12. Hiraiwa N., Hiraiwa M., Kannagi R. Human T-celI leukemia virus-1 encoded Tax protein transactivates α1→3fucosyltransferase Fuc-T VII, which synthesizes sialyl Lewis X, a selectin ligand expressed on adult T-cell leukemia cells. Biochem Biophys Res Commun. 231:1997;183-186.
13. Kang R., Saito H., Ihara Y.et al. Transcriptional regulation of the N-acetylglucosaminyl-transferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1. J Biol Chem. 43:1996;26706-26712.
14. Lu Y., Chaney W. Induction of N-acetylglucosaminyl-transferase V by elevated expression of activated or proto-Ha-ras oncogenes. Mol Cell Biochem. 122:1993;85-92.